BIOMAT Database Logo BIOMAT Database Logo

[Side effects of trimethoprim-sulfamethoxazole (co-trimoxazole)]. 1973

M R Veen

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex

Related Publications

M R Veen
Sulfamethoxazole-trimethoprim (co-trimoxazole).
August 1973, The Medical letter on drugs and therapeutics,
M R Veen
Proteus morganii meningitis treated with trimethoprim-sulfamethoxazole (co-trimoxazole).
July 1975, Clinical pediatrics,
M R Veen
Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
April 1981, Journal of clinical microbiology,
M R Veen
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
July 1996, The New England journal of medicine,
M R Veen
Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.
July 2009, Contact dermatitis,
M R Veen
Hematological side effects of co-trimoxazole.
January 1987, Infection,
M R Veen
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
December 1982, Drugs,
M R Veen
Co-trimoxazole, or just trimethoprim?
March 1986, Drug and therapeutics bulletin,
M R Veen
Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.
March 1980, Antimicrobial agents and chemotherapy,
M R Veen
Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
June 2013, International journal of antimicrobial agents,
Copied contents to your clipboard!